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ABSTRACT 
 
Spatial Analysis of County Level Influenza Vaccination Coverage Estimates 
 
By 
 
Seth Abram Meador 
 
3/22/18 
 
 
INTRODUCTION:  The Centers for Disease Control and Prevention (CDC) reported 43.3% of 
adults (>18) received a flu vaccination in the 2016-17 season (FluVaxView, 2018).  Despite 
long-standing recommendations and the enormous burden caused by the virus, vaccination 
coverage for flu is consistently low across seasons.  
 
AIMS:  This study examines influenza vaccination coverage among adults at the county level, in 
the contiguous United States (U.S.), to identify clusters of high and low coverage as well as 
assess access to care variables that could impact coverage levels. 
 
METHODS: County level influenza vaccination coverage estimates from the 2014 Behavioral 
Risk Factor Surveillance System (BRFSS) were examined to identify statistically significant 
clusters using global (Moran’s I) and local (Local Indicators of Spatial Association (LISA)) 
spatial clustering tests in GeoDa 1.10.  To examine spatial effects of area provider supply and 
population demand variables, regression analyses were performed in GeoDaSpace.  Independent 
variables were obtained from the Area Health Resource File (AHRF) and the National Council 
for Prescription Drug Program (NCPDP). 
 
RESULTS: The Moran’s I value comparing coverage estimates to the spatially lagged values 
was 0.48, indicating the coverage estimates are not spatially random. Five hundred sixty five 
counties were considered ‘High-High’, four hundred sixty three were ‘Low-Low’, and sixty 
seven had high coverage but were surrounded by counties with low coverage, designated as 
‘High-Low’.  ‘Low-High’ counties are defined as counties with low coverage surrounded by 
counties with high coverage. Forty counties were considered ‘Low-High’ in this analysis.  The 
final regression model used a regime to stratify counties by states that expanded Medicaid under 
the Affordable Care Act and those that did not.  Among counties in states that did not expand 
Medicaid, the variables per capita pharmacies, per capita clinics, and percent less than sixty five 
years with no health insurance had no statistically significant associations with the outcome.  In 
counties that were part of the Medicaid expansion, only per capita pharmacies and per capita 
clinics were not significant. 
 
DISCUSSION: Per capita health care providers were statistically significant and positively 
associated with influenza vaccination coverage in both regime models, but had a larger 
regression coefficient in the expanded Medicaid regime model.  
 
Key Words: Spatial Analysis, GIS 
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Introduction 
Annually, the U.S. experiences an influenza (flu) epidemic with unpredictable gradients 
of severity.  The virus is responsible for thousands of deaths and hospitalizations (CDC, 2018).  
The Centers for Disease Control and Prevention (CDC) reported 43.3% of adults (>18) received 
a flu vaccination in the 2016-17 season (FluVaxView, 2018).  Receiving an annual flu 
vaccination is considered an effective method of preventing the flu, and is recommended for 
everyone six months of age and older without contraindications by the Advisory Committee on 
Immunization Practices (Grohskopf et al., 2017).  Different vaccine types are available for use, 
including unadjuvanted, egg-based trivalent and quadrivalent inactivated influenza vaccines 
(IIV3 and IIV4), adjuvanted trivalent egg-based inactivated influenza vaccines (aIIV3), high-
dose trivalent egg-based inactivated influenza vaccines (hd IIV3), quadrivalent cell culture–
based inactivated influenza vaccines (ccIIV4), and recombinant trivalent influenza vaccines 
(RIV3) (Budd, et al., 2016).  The quadrivalent live attenuated intranasal influenza vaccine 
(LAIV4) was not been recommended for use in the 2017-18 season because of concerns about 
effectiveness (Budd, et al., 2016).  Despite long-standing recommendations and the enormous 
burden caused by the virus, vaccination coverage for flu is consistently low among adults 18-64 
years across seasons.  Examining contextual factors of vaccination coverage at a finer geographic 
resolution (county) may provide clues to better target specific populations.  
Using spatial data this analysis sought to answer the following: 1) were 2014 county level 
flu vaccination coverage estimates clustered locally among U.S. counties, or were the estimates 
spatially random?  It was hypothesized that statistically significant clusters of both high and low 
coverage estimates will be detected.  Findings of significant clusters would suggest that 
regression analyses include spatial effects.  2) In spatial regression, was the variation in coverage 
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across counties in the U.S. statistically and significantly related to area provider supply and 
population demand variables?  If so, which independent variables seem to have the greatest 
impact?  The ability to assess whether a county was influenced by adjacent counties, also known 
as spillover effect, is an additional benefit from estimating spatial regression.  As discussed in 
Trogdon and Ahn (2015) such spillovers would suggest that targeting interventions to increase 
influenza vaccination in one area could have spillover benefits that would lead to increases in 
neighboring areas as well. 
Literature Review 
The selection of literature regarding adult vaccination coverage and spatial analysis is 
limited in scope. However, similar methods have been utilized to assess childhood vaccination 
(Omer et al. 2008; Trogdon and Ahn, 2015) as well as stroke hospitalization clusters over time 
(Schieb, et al, 2013).  An analysis of immunization registry data from North Carolina revealed 
clusters of low coverage rates among uninsured and publicly insured children, concluding 
coverage was lower in areas of persistent poverty and shortages of providers, indicating out-of-
pocket costs are only one of numerous factors contributing to low coverage (Trogdon and Ahn, 
2015). Using the 2014 county level estimates provided by the Behavioral Risk Factor 
Surveillance System (BRFSS), this project provides a new perspective on identifying both 
clusters of above-average and below average-vaccination, the provider supply and population 
demand characteristics that define those areas, and how those characteristics compare across the 
two types of areas.  Additionally, this project can demonstrate the value of applying spatial 
techniques to gain new knowledge in public health.   
Barriers to influenza vaccination uptake have been identified consistently throughout the 
literature.  Coverage for adults (≥18) in the 2016-17 flu season was 43.3%, well below the 
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Healthy People 2020 target of 70% (HP2020, 2017).  With their analysis of the 2009 BRFSS 
data, Takayama et al. found a negative association between receiving the flu vaccine and having 
an income less than $35,000, as well as those without health insurance (2012).  This association 
continued despite increased coverage with advanced age.  Higher levels of flu coverage are 
generally seen among adults older than sixty five years as compared to adults eighteen to sixty 
four (FluVaxView, 2017), which is likely the result of mandatory coverage of the vaccine by 
Medicare and generally utilize health care more often than those less than sixty five years.  Lu et 
al. found similar results when analyzing data from the National Health Interview Survey (2013).  
They concluded that adults 18-64 years were more likely to have received the vaccine if they 
were employed, living at or above poverty, and had health insurance.  
Disparities in flu vaccination coverage by race were identified in the 2011-12 season by 
Lu et al. (2014) and remains a consistent theme throughout the literature.  In the 2016-17 season 
coverage for Asians was 52.8% while coverage for non-Hispanic whites was 47.5%, non-
Hispanic blacks 43.0%, Hispanics 46.2%, American Indian/Alaska Natives was 41.8%, and 
people of other or multiple races was 46.7% (FluVaxView, 2018). Addressing the enduring  
coverage gaps are difficult given the combination of factors, including: socio-demographic 
characteristics, patients and provider attitudes toward vaccination, awareness of 
recommendations, systems used in clinics serving different patient populations, preventive care, 
propensity to seek and accept vaccination, and quality of care received by racial/ethnic 
populations (Lu et al. 2014).  Quinn et al. noted a similar list of contributing factors for 
disparities in coverage in their study of flu vaccination among African Americans specifically 
(2018). 
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Healthcare providers, both medical and pharmacy trained, are instrumental in increasing 
flu vaccine uptake.  These providers are in a unique position to educate their patients and address 
potential concerns, with one literature review citing pregnant women rely almost entirely on their 
medical provider for information during pregnancy (Myers, 2016).  Routine visits to healthcare 
providers are essential to increasing coverage, and the inability to pay for the visit has been 
negatively associated with receiving the influenza vaccine in numerous studies (Takayama et al., 
2012; Lu et al., 2016; La et al., 2017).  However, few studies have examined the association 
between healthcare provider density and influenza vaccination coverage.  Gai & Gu combined 
individual level data from BRFSS and healthcare provider data from the Area Health Resource 
file and concluded an increase in provider density was associated with greater odds of receiving 
the flu vaccine (2014).  Associations between vaccination coverage and pharmacy density has 
been explored in greater detail.  Examining the same data set, but replacing per capita physicians 
with per capita pharmacies, Gai and Feng concluded the number of pharmacies per 1000 people 
was associated with greater odds of receiving a flu shot (2017).  Murphy et al. found that 
pharmacies in medically underserved areas administered one third of all influenza vaccinations 
in the 2009-10 flu season (2012).  
Knowledge, attitudes, and beliefs have tremendous influence on the decision to receive 
the flu vaccine.  In a systematic review of the literature Yeung et al. concluded that perceived 
vaccine efficacy and safety were main deterrents to receiving the vaccine, and were more 
influential factors than an increase in knowledge of influenza (2016). Internet panel surveys of 
pregnant women revealed concern of the vaccine’s safety and effectiveness.  However, women 
that were hesitant to get the vaccine but received a recommendation from their provider were 
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more likely to be vaccinated than those that did not receive the recommendation (Ding et al., 
2017).   
Data Sources 
 County level influenza vaccination coverage estimates were obtained from the BRFSS 
Small Area Estimation (SAE) project.  Due to an increased demand for local level data, BRFSS 
developed methods to produce county level prevalence estimates for flu vaccinations as well as 
other public health indicators for health policy and program evaluation (BRFSS, 2018).  The 
BRFSS SAE method relied on data from 4 sources: 1) the 2013 BRFSS (n = approximately 
430,000 individual survey responses), which provides data on health behaviors, demographic 
characteristics, and county; 2) the 2008–2012 American Community Survey (ACS) Public Use 
Microdata Sample (PUMS), which provided individual-level data with person weights (n = 
approximately 11,600,000) and Public Use Microdata Areas (PUMAs); 3) the Missouri Census 
Geographic Equivalency File (GEOCORR), which matched counties and PUMAs; 4) the 2013 
Nielsen Claritas population totals used for weighting to county-level populations (Pierannunzi et 
al, 2016).  Prevalence estimates were created by aggregating individual level probabilities, 
generated by linear random effects models, to the county level.  Variables used in the final 
specified model included demographic factors such as age, sex, race or ethnicity, and used 
county as the random effect.  Internal validity was checked by comparing imputed estimates to 
estimates generated directly from BRFSS data.  To verify external validity, imputed estimates for 
the proportion of the population (18-64 years) without health insurance were compared to 
proportions generated by the ACS. 
 In the empirical model estimated here, demographic variables were explicitly excluded 
because these had been used to generate the influenza vaccination coverage (outcome) estimates.  
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Predictor variables in the empirical model included provider supply characteristics and 
population demand characteristics thought to be important in this ecological model of flu 
vaccination uptake.  Most of these variables were obtained from The Area Health Resource File 
(AHRF), 2016-17.  This data set acts as a repository for dozens of population health related data 
sources and provides estimates at the county, state, and national levels.  More than fifty sources 
are combined in the AHRF under eight categories: Health Care Professions, Health Facilities, 
Population Characteristics, Economics, Health Professions Training, Hospital Utilization, 
Hospital Expenditures, and Environment (HRSA, 2018).  In conjunction with AHRF data, 
pharmacy location data from the National Council for Prescription Drug Program (NCPDP) was 
used in the final model.  NCPDP provides unique identification numbers to pharmacies to 
improve interactions with the federal government.  All data provided to NCPDP is self-reported 
from each pharmacy. 
Measures 
To determine the influence of supply variables such as access to care on influenza 
vaccination, variables were created for per capita healthcare providers, per capita clinics, and per 
capita licensed pharmacists by county.  Healthcare providers included primary care doctors, 
obstetricians and gynecologists (OB/GYNs), Physician’s Assistants, and Nurse Practitioners.  
Federally Qualified Health Centers were combined with Rural Health Clinics to calculate the 
variable per capita clinics.  A file from NCPDP containing pharmacy addresses was geocoded 
using ESRI’s ArcMap to determine the number of pharmacies per county.  After completing a 
quality assurance check on the unmatched addresses, the geocoded addresses were spatially 
joined to a U.S. county shapefile.  When specified, a new variable is created during the join 
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process that produces a sum of all points in each polygon (county).  The sum was divided by the 
total population in each county to calculate the per capita pharmacist variable.   
 Because of strong evidence correlating insurance status with vaccination status, the 
variable percent of persons under sixty five years without health insurance, from the AHRF, was 
included in the model.  Socioeconomic factors reflecting population demand included percent 
persons in poverty, and percent urban population of each county.  
Methods 
 Spatial autocorrelation is defined as the correlation among values of a single variable 
with adjacent values in terms of their geospatial location.  When groups of values are similar 
among neighboring locations, there is spatial clustering in the values.  When being more similar 
to a neighbor is due to some reciprocation – also known as a ‘spillover’ effect – then neighboring 
observations are not independent, which can cause problems in regression analysis (Griffith, 
1987).  Since the early 1950s the global Moran’s I test has been used to quantify the presence of 
spatial clustering and is applicable to nearly any discipline that incorporates spatially referenced 
data.  Subsequently, a statistical procedure was developed using the global Moran’s I logic that 
allows for the decomposition of global indicators into the local contribution of each individual 
observation to detect statistically significant high and low local clusters, relative to the mean of 
all observations (Anselin, 1995).   
 County level vaccination coverage clusters were assessed using global and local spatial 
clustering tests.  All spatial analyses were conducted with GeoDa 1.10. Assessment began with 
creating a spatial weights matrix to establish spatial relationships among counties in the data set.  
Because the data are aggregated into county polygons, queen contiguity weights will be used to 
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identify the spatial neighbors for each county.  The Global Moran’s I is used to determine if the 
data are spatially random or if clustering is present.  If the Moran’s I is a positive number 
between 0 and 1 and the p-value is significant (α≤.05), then we can say local clustering is 
occurring somewhere among the map features.  To locate the local clusters, we conduct the 
Local Moran’s I test.  The output is displayed on a map with five classifications as either ‘Not 
Significant’, ‘High-High Cluster’, ‘Low-Low Cluster’, ‘High-Low Outlier’, or ‘Low-High 
Outlier’.  A ‘High-High Cluster’ is defined as the central county and its neighbors have values 
that are statistically significantly different than the mean.  ‘Low-Low Clusters’ are defined in the 
same way except their values are below the mean.  ‘High-Low’ or ‘Low-High’ indicate a central 
county with a statistically significantly different value that is the inverse of its neighbors.  
 Next, if significant clusters were found, we would expect that the regression analysis 
should include spatial effects.  The exploratory Ordinary Least Squares (OLS) regression 
analysis included all areas and all predictor variables together, and specification tests on the 
residuals of the regression were used to determine what refinements to the simple OLS model are 
required for producing reliable estimates.  These explorations revealed that spatial spillovers 
were present in the data.  Further analysis grouping the Medicaid expansion and non-expansion 
states suggested that groupwise heteroscedasticity was confounding the estimates in a single-
equation model.   The final spatial regression model was stratified into two separate equations to 
represent the group of states that expanded Medicaid under the Affordable Care Act in 2014 
(ACA, 2018), versus the group that did not.  
To address unmodeled spatial heterogeneity and spatial autocorrelation, GeoDaSpace was 
used to estimate a third model, including both lag and error terms, and used a spatial regime that 
differentiated states which expanded Medicaid under the Affordable Care Act (ACA) by 2014.  
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The model was specified with General Method of Moments and ‘KP-HET’ which accounts for 
spatial heteroskedasticity to produce robust standard errors.  Results are estimated separately for 
each of the two groups of states (based on the predefined regimes).  The method used allowed for 
groupwise heteroskedasticity, estimating separate equations while correlating errors across 
equations to enhance efficiency.  The results also provided a Chow test of whether the 
coefficients were stable across the Regimes. 
Using the descriptive statistics for each covariate and the outcome variable, the standard 
deviations are used to interpret the quantitative results for the significant regression coefficients.  
We answer the question: by how much does flu coverage change (in terms of its own mean and 
standard deviation) when the explanatory variable is increased one standard deviation from its 
mean?   This approach allows the interpretation to bypass the units of measurement, which can 
make estimates appear very large or small, and focuses on the quantitative impacts rather than 
solely the statistical significance (Kuo & Mobley, 2016). 
Spatial Clustering Analysis 
 It’s hypothesized that flu vaccination coverage among adults is not spatially random 
among counties in the U.S.  The univariate global Moran’s I test can detect clustering across the 
area of interest by comparing the coverage estimate for each county to the mean of the data set.  
A Moran’s I value between zero and one indicates clustering somewhere in the areas of interest.  
A value between zero and negative one suggests spatial randomness among counties.  Prior to 
running the test, a spatial weights matrix is generated using queen contiguity to specify the 
neighboring structure for each county.  The Moran’s I value comparing coverage estimates to the 
spatially lagged values was 0.48, indicating the coverage estimates are not spatially random.  The 
univariate local Moran’s I tool was used to locate clusters of high and low coverage. 
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 The results of the Local Indicators of Spatial Association (LISA) test display only the 
‘core’ counties at the center of the statistically significant (α < .05) cluster in the map (Figure 1).  
Five hundred sixty five counties were considered ‘High-High’, four hundred sixty three were 
‘Low-Low’, and sixty seven had high coverage but were surrounded by counties with low 
coverage, designated as ‘High-Low’.  Forty counties had low coverage surrounded by counties 
with high coverage, designated as ‘Low-High’.  The significant Moran’s I also provides a 
rational to conduct a spatial regression to assess the variables with the most impact on influenza 
coverage. 
Regression Analysis 
 Because it is hypothesized that influenza vaccination coverage does not exhibit a spatially 
random pattern among U.S. counties, spatial considerations are needed in regression modeling.  
There are possibly two separate spatial processes at work, spatial regimes and spatially correlated 
variables and errors across the counties. 
 A correlation matrix was created using the correlation procedure in SAS to limit 
problems associated with multicollinearity among predictor variables.  Not all variables initially 
selected for the analysis were included in the final model due to the effect of measuring similar 
county characteristics.  For example, percent of the county population in poverty and median 
household income both measure wealth among the county populations, and appear to be highly 
correlated with a correlation coefficient of -0.78.  This would be an expected outcome as one 
would assume that as income increases, the poverty rate decreases.  The percent poverty variable 
resembled a similar pattern as the LISA results and was chosen for the final model.  Because the 
flu vaccine should be covered by health insurance for everyone six months and older, and 
Medicare provides vaccinations for those older than sixty five years, the variable measuring the 
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percent of those less than sixty five years without health insurance was also included in the final 
model.  Using quantile classification, thematic maps were created of all variables and visually 
compared to the results of the LISA analysis map.  The map displaying urbanicity showed little 
similarity to the LISA map, but was included in the model because of prior studies showing 
associations between living in an urban area and receiving a flu vaccine (Galarce, et al., 2011).  
Per capita health care provider, clinic, and pharmacy were included in the final model as well to 
identify associations between flu vaccination coverage and access to care. 
Results 
 To discover the model that best fits the data, one starts with OLS, and uses a series of 
diagnostic tests on the residuals to further refine the model.  OLS was used to specify the first 
model using the spatial weights file created for the cluster analysis to assess spatial effects that 
may be left over in the OLS model residuals.  Model diagnostics suggested that some 
improvements were needed over the OLS model.  The multicollinearity condition number (11.9) 
is significantly lower than the suggested limit of 50 indicating the explanatory variables are not 
correlated with one another, so no problems with multicollinearity are evident with the group of 
regressors chosen.  The Moran’s I test of spatial dependence in the residuals was significant, as 
expected.  However, to determine the best alternative model (lag or error), a comparison was 
made between the Robust Lagrange Multiplier lag and error tests.  Both non-robust tests were 
significant, but only the robust lag test was significant, thus the subsequent regression estimated 
was the spatial lag model. 
  The spatial lag model improved fit as evidenced by the reduced log likelihood values (-
9920 compared to -9406).   With the exception of per capita clinic and per capita pharmacy, all 
variables were statistically significant.  Percent urban (-0.021), percent poverty (-0.098), and 
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percent less than sixty five years without health insurance (-0.077) had negative coefficients, 
suggesting an inverse relationship to influenza vaccination coverage. The additional lag variable 
in the model was highly significant, illustrating the significant spillover effects among adjacent 
counties.  The Breusch-Pagan test for heteroskedasticity was highly significant, suggesting that 
the lag model was not sufficient to explain all of the spatial heterogeneity in the data.   
Among counties in states that did not expand Medicaid variables per capita pharmacies, 
per capita clinics, and percent less than sixty five years with no health insurance were not 
statistically significant.  In counties that were part of the Medicaid expansion, only per capita 
pharmacies and per capita clinics were not significant.  Additionally, results of the Chow test 
comparing variables across regimes revealed only per capita healthcare providers was 
statistically significantly different between states that expanded Medicaid and those that did not.  
Discussion 
Figure 2 shows the states that expanded Medicaid.  Comparing this to Figure 1, it is 
evident that there may be some relationship between Medicaid expansion status and vaccination 
coverage.  The counties designated ‘High-Low’ and ‘Low-High’ in the spatial clustering analysis 
are particularly interesting because they are considered outliers. This designation indicates they 
are statistically significantly different from their neighboring counties with regards to flu 
vaccination coverage. Further investigation is required to determine which factors would lead a 
particular county to have higher or lower vaccination coverage than surrounding areas.      
Per capita healthcare provider was statistically significant and positively correlated with 
flu vaccination coverage in both regimes, however the regression coefficient was larger in the 
expanded Medicaid regime compared to unexpanded.  This larger effect suggests that Medicaid 
expansion may have enhanced the effect of additional healthcare providers on access to 
13 
 
vaccinations following the coverage of preventative health services by health insurance plans as 
specified by the ACA.  Corriero et al. found increases in human papillomavirus (HPV) 
vaccination coverage in their examination of The National Health and Nutrition Examination 
Survey (NHANES) data pre and post implementation of ACA (2018).  Providers may also be 
more inclined to recommend the vaccine to patients because of improvements in reimbursement 
that accompany expansion of the percentage of populations covered by health insurance (Hurley 
et al., 2017).  Results of a 2013 survey of providers showed physicians reported not 
recommending vaccinations to their adult patients and patients frequently refusing vaccines for 
financial reasons (Hurley et al., 2017).  
 Among states that did not expand Medicaid, the effect of a one standard deviation change 
in per capita healthcare providers increased influenza vaccination coverage by about a quarter of 
a percent (0.265).  States that expanded Medicaid saw an increase of about three quarters of a 
percent (0.748) for one standard deviation change in per capita healthcare provider.  Quantifying 
the magnitude of effects was done only for per capita healthcare provider because of results of 
the Chow test showed these effects were significantly different across the Regimes.  These 
effects are small relative to the standard deviations of influenza vaccination coverage (6.35-did 
not expand Medicaid; 6.11-did expand Medicaid).  However, it provides further evidence that 
increased access to and affordability of the flu vaccine may increase vaccination coverage. 
Negative correlation coefficients for percent poverty in both models was an expected 
outcome as previous studies have reported lower influenza vaccination coverage among those 
living in poverty (Lu, et al.2016; Redelings, et al. 2011).  Among states that expanded Medicaid, 
the percent less than sixty five years with no health insurance was statistically significant with a 
correlation coefficient of -0.12, meaning for every one percent increase in those without 
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insurance, there was a twelve percent decrease in influenza vaccination coverage.  There is some 
speculation as to what is responsible for this outcome.  This uninsured variable is capturing those 
in the population that make too much money to qualify for Medicaid (under the new, more 
generous rules) but not enough to buy insurance.  The Chow test does not find this negative 
effect to be significantly different across the regimes.  Generally, one would expect a higher 
uninsured rate to be associated with a lower vaccination rate.  Another postulation would be that 
coverage is consistently lower for those less than sixty five years (FluVaxView, 2018) and thus 
health insurance status would not affect their decision to be vaccinated.  Further investigation is 
required to determine possible associations. 
   Several limitations should be taken into consideration for interpretation of the results.  
1) The influenza vaccination coverage estimates from BRFSS were modeled using SAE methods 
and might not reflect the true coverage status in a particular county.  These estimates have gone 
through validity checks but may be problematic where data for independent variables was sparse.  
This could also account for the strong need to include both spatial error and spatial lag terms in 
the final models. Some of the spatial autocorrelation could have been a result of the estimation 
methods used to produce the vaccination coverage variable, which highlights the need for using 
correctly specified spatial regression models when analyzing these data.  2) Alaska, Hawaii, and 
island counties in Washington and Massachusetts were excluded due to the requirement for 
contiguity among polygons to complete the analysis.  Counties in these areas are considered 
‘spatial islands’ and would therefore not have neighbors.  3) Areas of high or low coverage in the 
cluster analysis are in relation to the mean coverage estimate of all counties included in the data 
set.  Influenza vaccination coverage may not be considered high or low according to state health 
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department standards.  4) Flu vaccination coverage is based on self-report from survey 
respondents and may be subject to recall bias. 
 The application of spatial analysis to vaccination coverage data is a relatively new 
technique.  With the availability of vaccination coverage data at higher geographic resolutions 
(county, zip code, etc.), investigators can identify pockets of low coverage in need of vaccination 
services during an outbreak or an epidemic.  These techniques may also provide insight on 
identifying disparities that may not be revealed in large surveys.  Future research should focus on 
local level effects of campaigns to increase coverage.  Despite state and national efforts to 
increase access by reducing the cost burden of flu vaccination, other factors are equally as 
important and should include providing consistent access to healthcare providers.  
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Table 1. Sample Statistics for States that did not Expand Medicaid      
Variable Mean SD 
Economic Conditions   
     Percent Persons in Poverty 17.5385 6.5644 
Health Insurance   
    % <65 without Health Insurance 16.5525 4.6697 
Access to Care   
   Per Capita Healthcare Providers 
   Per Capita Clinics 
   Per Capita Licensed Pharmacists 
162.3827 
18.1491 
31.2386 
120.2696 
24.3520 
16.6917 
Rural/Urban   
   Percent Urban Population 39.3341 31.3692 
Influenza Vaccination Coverage 39.1635 6.3532 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
 
 
 
Table 2. Sample Statistics for States that did Expand Medicaid      
Variable Mean SD 
Economic Conditions   
     Percent Persons in Poverty 15.8126 6.1191 
Health Insurance   
    % <65 without Health Insurance 10.7487 3.4161 
Access to Care   
   Per capita Healthcare Providers 
   Per Capita Clinics 
   Per Capita Licensed Pharmacists 
179.7315 
17.0611 
29.8400 
102.5019 
24.0202 
14.0473 
Rural/Urban   
   Percent Urban Population 44.8907 31.2227 
Influenza Vaccination Coverage 40.1431 6.1157 
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Table 3. Spatial Regime Regression Analysis of Influenza Vaccination Coverage Among 
Adults in U.S. Counties 
Variable Medicaid Not Expanded Medicaid Expanded 
 Coeff St. 
Error 
p-value Coeff St. 
Error 
p-value 
Percent Persons in Poverty -0.0728 0.0182 0.0000 -0.0561 0.0204 0.0060 
% <65 without Health 
Insurance 
-0.0428 0.0259 0.0980 -0.1202 0.0530 0.0235 
Per capita Healthcare 
Providers* 
0.0022 0.0010 0.0263 0.0073 0.0018 0.0000 
Per Capita Clinics 0.0000759 0.0046 0.9869 0.0069 0.0071 0.3279 
Per Capita Licensed 
Pharmacists 
0.0068 0.0070 0.3293 0.0042 0.0095 0.6574 
Percent Urban Population -0.0200 0.0047 0.0000 -0.0164 0.0066 0.0137 
Flu Vaccination Lag  0.7514 0.0644 0.0000 0.7692 0.0749 0.0000 
Lambda (Error) -0.6813 0.0783 0.0000 -0.6035 0.0836 0.0000 
*Variable was statistically significantly different across regimes. 
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Figure 1. Cluster Analysis Results 
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Figure 2. Medicaid Expansion States 
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